Sterling Financial Planning, Inc. Cns Pharmaceuticals, Inc. Transaction History

Sterling Financial Planning, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 02, 2022	SELL	$0.7 - $1.54 $420 - $924	-600 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$1.71 - $2.42 $1,026 - $1,452	600 New	600 $1,000

100

Ticker CNSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,032,500
Market Cap $4.4M
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....

Get notified when there are updates to the investment portfolio of Sterling Financial Planning, Inc., based on Form 13F filings with the SEC.

Stay updated on Sterling Financial Planning, Inc. with notifications on news.